IN DEVELOPMENT
DUR-928
An endogenous, orally bioavailable small molecule in development for chronic liver disease and acute organ injury.
LEARN MORE
ORADURTM-Methylphenidate ER
An investigational once-daily formulation of the widely-prescribed ADHD medication methylphenidate under evaluation for resistance to common methods of tampering.
LEARN MORE
POSIMIR®
(bupivacaine extended-release solution)
An investigational non-opioid, locally-acting analgesic being evaluated for its ability to deliver 3 days of continuous pain relief after surgery.
LEARN MORE
Investigational Long-acting HIV Product
An investigational long-acting injectable HIV product incorporating DURECT’s SABER® depot technology. Under development with Gilead Sciences, Inc.
LEARN MORE
